Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 10 | 2023 | 643 | 2.960 |
Why?
|
| Vasopressins | 4 | 2019 | 42 | 2.460 |
Why?
|
| Shock, Septic | 5 | 2023 | 80 | 2.450 |
Why?
|
| Vasoconstrictor Agents | 4 | 2019 | 88 | 2.370 |
Why?
|
| Biopsy, Fine-Needle | 6 | 2021 | 116 | 2.110 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 5 | 2023 | 49 | 1.820 |
Why?
|
| Norepinephrine | 3 | 2018 | 119 | 1.800 |
Why?
|
| Bronchoscopy | 5 | 2019 | 79 | 1.530 |
Why?
|
| Dyspnea | 5 | 2022 | 78 | 1.410 |
Why?
|
| Pleural Effusion | 3 | 2019 | 38 | 1.290 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2017 | 23 | 1.120 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2019 | 385 | 1.060 |
Why?
|
| Intensive Care Units | 5 | 2019 | 232 | 1.030 |
Why?
|
| Humans | 44 | 2023 | 54397 | 0.810 |
Why?
|
| Aged | 18 | 2019 | 10061 | 0.810 |
Why?
|
| Tracheostomy | 2 | 2020 | 81 | 0.800 |
Why?
|
| Retrospective Studies | 18 | 2023 | 6460 | 0.780 |
Why?
|
| Ticlopidine | 3 | 2016 | 57 | 0.780 |
Why?
|
| Male | 29 | 2022 | 27348 | 0.770 |
Why?
|
| Nausea | 1 | 2021 | 53 | 0.770 |
Why?
|
| Pleurodesis | 2 | 2017 | 8 | 0.770 |
Why?
|
| Vomiting | 1 | 2021 | 73 | 0.750 |
Why?
|
| Diarrhea | 1 | 2021 | 90 | 0.750 |
Why?
|
| Thoracoscopy | 2 | 2019 | 20 | 0.730 |
Why?
|
| Cough | 3 | 2022 | 55 | 0.720 |
Why?
|
| Middle Aged | 19 | 2019 | 13083 | 0.720 |
Why?
|
| Esophagus | 2 | 2017 | 80 | 0.720 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2016 | 179 | 0.710 |
Why?
|
| Bronchoscopes | 2 | 2016 | 11 | 0.690 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 25 | 0.690 |
Why?
|
| Pleural Diseases | 2 | 2016 | 14 | 0.680 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 15 | 0.680 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 27 | 0.680 |
Why?
|
| Pleura | 2 | 2015 | 15 | 0.670 |
Why?
|
| Time Factors | 4 | 2019 | 3210 | 0.660 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 30 | 0.660 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 74 | 0.650 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2018 | 13 | 0.640 |
Why?
|
| Female | 26 | 2022 | 28474 | 0.640 |
Why?
|
| Ultrasonography | 2 | 2017 | 486 | 0.630 |
Why?
|
| Hypotension | 1 | 2019 | 67 | 0.630 |
Why?
|
| Diagnosis, Differential | 6 | 2022 | 1141 | 0.630 |
Why?
|
| Sclerosing Solutions | 1 | 2017 | 14 | 0.620 |
Why?
|
| Respiratory Insufficiency | 3 | 2016 | 127 | 0.620 |
Why?
|
| Bronchial Diseases | 1 | 2017 | 8 | 0.620 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2017 | 6 | 0.610 |
Why?
|
| Myofibroblasts | 1 | 2018 | 48 | 0.610 |
Why?
|
| Confusion | 1 | 2017 | 20 | 0.610 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 28 | 0.600 |
Why?
|
| Cryptococcosis | 1 | 2017 | 21 | 0.600 |
Why?
|
| Middle Cerebral Artery | 1 | 2017 | 39 | 0.600 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 29 | 0.590 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 146 | 0.590 |
Why?
|
| Catheterization | 1 | 2017 | 108 | 0.580 |
Why?
|
| Referral and Consultation | 1 | 2019 | 308 | 0.580 |
Why?
|
| Endocarditis, Bacterial | 1 | 2017 | 44 | 0.580 |
Why?
|
| Mitral Valve | 1 | 2017 | 70 | 0.580 |
Why?
|
| Tracheal Neoplasms | 1 | 2016 | 9 | 0.570 |
Why?
|
| Pyrethrins | 1 | 2016 | 4 | 0.570 |
Why?
|
| Flea Infestations | 1 | 2016 | 4 | 0.570 |
Why?
|
| Granular Cell Tumor | 1 | 2016 | 7 | 0.570 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2016 | 7 | 0.570 |
Why?
|
| Midodrine | 1 | 2016 | 6 | 0.570 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2016 | 6 | 0.570 |
Why?
|
| Insecticides | 1 | 2016 | 19 | 0.570 |
Why?
|
| Critical Illness | 5 | 2020 | 344 | 0.560 |
Why?
|
| Lymphoma | 1 | 2017 | 72 | 0.550 |
Why?
|
| Adult | 15 | 2023 | 14210 | 0.550 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2015 | 12 | 0.540 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 44 | 0.540 |
Why?
|
| Peptic Ulcer | 1 | 2015 | 13 | 0.540 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 20 | 0.530 |
Why?
|
| Tracheal Diseases | 1 | 2015 | 12 | 0.530 |
Why?
|
| Osteochondrodysplasias | 1 | 2015 | 14 | 0.530 |
Why?
|
| Vascular Access Devices | 1 | 2015 | 29 | 0.530 |
Why?
|
| Gastrointestinal Agents | 1 | 2015 | 37 | 0.530 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2015 | 34 | 0.520 |
Why?
|
| Critical Care | 1 | 2017 | 234 | 0.510 |
Why?
|
| Trachea | 1 | 2015 | 51 | 0.510 |
Why?
|
| Treatment Outcome | 9 | 2018 | 5612 | 0.510 |
Why?
|
| Adrenal Glands | 1 | 2014 | 38 | 0.510 |
Why?
|
| Hemorrhage | 1 | 2016 | 209 | 0.510 |
Why?
|
| Magnesium | 1 | 2014 | 42 | 0.490 |
Why?
|
| Myasthenia Gravis | 1 | 2014 | 17 | 0.490 |
Why?
|
| Registries | 1 | 2017 | 554 | 0.480 |
Why?
|
| Plasma Cells | 1 | 2015 | 239 | 0.470 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 174 | 0.470 |
Why?
|
| Deglutition Disorders | 1 | 2014 | 71 | 0.460 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 423 | 0.440 |
Why?
|
| Cisplatin | 1 | 2015 | 351 | 0.440 |
Why?
|
| Thrombosis | 1 | 2015 | 243 | 0.430 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 474 | 0.430 |
Why?
|
| Smoking | 1 | 2016 | 553 | 0.410 |
Why?
|
| Neoplasms | 1 | 2021 | 1322 | 0.390 |
Why?
|
| Internship and Residency | 1 | 2015 | 501 | 0.350 |
Why?
|
| Endosonography | 3 | 2023 | 96 | 0.340 |
Why?
|
| Obesity | 1 | 2017 | 1203 | 0.320 |
Why?
|
| Organ Dysfunction Scores | 2 | 2017 | 17 | 0.310 |
Why?
|
| Arterial Pressure | 2 | 2018 | 50 | 0.310 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1249 | 0.300 |
Why?
|
| Sepsis | 2 | 2023 | 250 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 1222 | 0.290 |
Why?
|
| Rare Diseases | 2 | 2018 | 46 | 0.290 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 401 | 0.280 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1300 | 0.280 |
Why?
|
| Incidence | 3 | 2019 | 1084 | 0.280 |
Why?
|
| Vancomycin | 2 | 2017 | 88 | 0.270 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 426 | 0.270 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 286 | 0.270 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1045 | 0.270 |
Why?
|
| Acute Disease | 2 | 2016 | 403 | 0.250 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 805 | 0.250 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 3431 | 0.250 |
Why?
|
| Lymph Nodes | 2 | 2017 | 284 | 0.240 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2022 | 12 | 0.220 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2022 | 6 | 0.220 |
Why?
|
| Dizziness | 1 | 2022 | 13 | 0.210 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 428 | 0.210 |
Why?
|
| Steroids | 1 | 2021 | 55 | 0.190 |
Why?
|
| Prospective Studies | 2 | 2018 | 2606 | 0.190 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2019 | 26 | 0.180 |
Why?
|
| Faculty | 1 | 2020 | 84 | 0.180 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 61 | 0.180 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 11 | 0.180 |
Why?
|
| Oncology Service, Hospital | 1 | 2019 | 14 | 0.170 |
Why?
|
| Ferritins | 1 | 2019 | 31 | 0.170 |
Why?
|
| Cocaine | 1 | 2019 | 184 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 152 | 0.160 |
Why?
|
| Communication | 1 | 2020 | 265 | 0.160 |
Why?
|
| Social Media | 1 | 2020 | 105 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 126 | 0.160 |
Why?
|
| Students, Medical | 1 | 2020 | 178 | 0.150 |
Why?
|
| Heart Ventricles | 1 | 2019 | 271 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 146 | 0.150 |
Why?
|
| Sutures | 1 | 2017 | 45 | 0.150 |
Why?
|
| Lung Abscess | 1 | 2017 | 6 | 0.150 |
Why?
|
| Catheters, Indwelling | 1 | 2017 | 68 | 0.150 |
Why?
|
| Serratia Infections | 1 | 2017 | 8 | 0.150 |
Why?
|
| Etomidate | 1 | 2016 | 6 | 0.150 |
Why?
|
| Drainage | 1 | 2017 | 79 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 75 | 0.150 |
Why?
|
| Esophagectomy | 1 | 2017 | 34 | 0.150 |
Why?
|
| Bronchial Fistula | 1 | 2016 | 5 | 0.150 |
Why?
|
| Anesthetics, Intravenous | 1 | 2016 | 26 | 0.150 |
Why?
|
| Cocaine-Related Disorders | 1 | 2019 | 246 | 0.150 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 22 | 0.150 |
Why?
|
| Device Removal | 1 | 2017 | 97 | 0.150 |
Why?
|
| Bronchi | 1 | 2017 | 51 | 0.140 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 14 | 0.140 |
Why?
|
| Pneumonia | 1 | 2018 | 129 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 825 | 0.140 |
Why?
|
| Young Adult | 2 | 2017 | 4319 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 62 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 47 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2017 | 225 | 0.140 |
Why?
|
| Penicillanic Acid | 1 | 2016 | 23 | 0.140 |
Why?
|
| Cephalosporins | 1 | 2016 | 33 | 0.140 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 100 | 0.140 |
Why?
|
| Airway Obstruction | 1 | 2016 | 51 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 325 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 514 | 0.140 |
Why?
|
| United States | 2 | 2017 | 5209 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2016 | 91 | 0.130 |
Why?
|
| Cost Savings | 1 | 2015 | 67 | 0.130 |
Why?
|
| Inservice Training | 1 | 2015 | 41 | 0.130 |
Why?
|
| Recurrence | 1 | 2017 | 692 | 0.130 |
Why?
|
| Catheters | 1 | 2015 | 33 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 184 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2015 | 22 | 0.130 |
Why?
|
| Drug Utilization | 1 | 2015 | 73 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 600 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2017 | 290 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2017 | 411 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 295 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 291 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 124 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2017 | 466 | 0.120 |
Why?
|
| Survival Rate | 1 | 2017 | 954 | 0.120 |
Why?
|
| Echocardiography | 1 | 2017 | 392 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 231 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 363 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2016 | 587 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 79 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 922 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 645 | 0.110 |
Why?
|
| Antifungal Agents | 1 | 2016 | 363 | 0.110 |
Why?
|
| Thoracostomy | 1 | 2012 | 13 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 1199 | 0.110 |
Why?
|
| Chest Tubes | 1 | 2012 | 23 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1090 | 0.110 |
Why?
|
| Hospitalization | 1 | 2017 | 704 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2013 | 184 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2016 | 1362 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 404 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2015 | 1547 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1035 | 0.090 |
Why?
|
| Cronobacter sakazakii | 1 | 2009 | 5 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2009 | 18 | 0.080 |
Why?
|
| Osteomyelitis | 1 | 2009 | 124 | 0.080 |
Why?
|
| Polymyxin B | 1 | 2023 | 5 | 0.060 |
Why?
|
| Adolescent | 1 | 2015 | 6901 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2023 | 125 | 0.060 |
Why?
|
| Dogs | 1 | 2022 | 216 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2390 | 0.050 |
Why?
|
| Research Design | 1 | 2023 | 375 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 3050 | 0.050 |
Why?
|
| Systole | 1 | 2019 | 80 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2019 | 61 | 0.040 |
Why?
|
| Education, Medical | 1 | 2020 | 104 | 0.040 |
Why?
|
| Serratia marcescens | 1 | 2017 | 8 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2019 | 259 | 0.040 |
Why?
|
| Arkansas | 2 | 2016 | 2101 | 0.040 |
Why?
|
| Piperacillin | 1 | 2016 | 25 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 113 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2016 | 262 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 131 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 8 | 0.030 |
Why?
|
| Dilatation | 1 | 2013 | 27 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 683 | 0.030 |
Why?
|
| Patient Safety | 1 | 2013 | 121 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1229 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 2126 | 0.020 |
Why?
|
| Discitis | 1 | 2009 | 8 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 14411 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 1616 | 0.010 |
Why?
|